Literature DB >> 34319393

Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine.

Eric Tano1, Stephanie San Martin1, Stephen Girgis1, Yadira Martinez-Fernandez2, Carolina Sanchez Vegas3.   

Abstract

On May 10, 2021, the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) was expanded to include adolescents (May 10, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use). We describe clinical characteristics of 8 adolescents who presented over the course of 36 days to Nicklaus Children's Hospital with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  BNT162b2; COVID-19 vaccine; myocarditis; pericarditis

Year:  2021        PMID： 34319393     DOI： 10.1093/jpids/piab060

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  24 in total

Review 1.  Myocarditis after COVID-19 mRNA vaccination: A systematic review of case reports and case series.

Authors:  Dae Yong Park; Seokyung An; Amandeep Kaur; Saurabh Malhotra; Aviral Vij
Journal:  Clin Cardiol       Date:  2022-06-02       Impact factor: 3.287

Review 2.  Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis-A systematic review.

Authors:  Jan M Federspiel; Frank Ramsthaler; Mattias Kettner; Gerhard Mall
Journal:  Rechtsmedizin (Berl)       Date:  2022-07-20       Impact factor: 1.112

Review 3.  Comorbidities and Symptomatology of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-Related Myocarditis and SARS-CoV-2 Vaccine-Related Myocarditis: A Review.

Authors:  Sarah Cushion; Vania Arboleda; Yousef Hasanain; Michelle Demory Beckler; Patrick Hardigan; Marc M Kesselman
Journal:  Cureus       Date:  2022-04-12

4.  One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business.

Authors:  Ravi Jhaveri
Journal:  Clin Ther       Date:  2021-11-25       Impact factor: 3.393

Review 5.  Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines.

Authors:  Yandi Zhang; Jo-Lewis Banga Ndzouboukou; Mengze Gan; Xiaosong Lin; Xionglin Fan
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

6.  Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022.

Authors:  Kevin J Downes; Victoria A Statler; Rachel C Orscheln; Melissa K Cousino; Michael Green; Marian G Michaels; William J Muller; Tanvi S Sharma; Lara A Danziger-Isakov; Monica I Ardura
Journal:  J Pediatric Infect Dis Soc       Date:  2022-02-23       Impact factor: 3.164

7.  Myocarditis following mRNA Covid-19 vaccination: A pooled analysis.

Authors:  Ioannis Bellos; Vasilios Karageorgiou; Dana Viskin
Journal:  Vaccine       Date:  2022-02-07       Impact factor: 4.169

Review 8.  Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations.

Authors:  John R Power; Lucas K Keyt; Eric D Adler
Journal:  Expert Rev Cardiovasc Ther       Date:  2022-04-18

9.  The COVID-19 pandemic in children and young people during 2020-2021: A complex discussion on vaccination.

Authors:  Igor Rudan; Davies Adeloye; Vittal Katikireddi; Josie Murray; Colin Simpson; Syed Ahmar Shah; Chris Robertson; Aziz Sheikh
Journal:  J Glob Health       Date:  2021-12-25       Impact factor: 7.664

10.  mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.

Authors:  Utkarsh Kohli; Lavina Desai; Devyani Chowdhury; Ashraf S Harahsheh; Alexandra B Yonts; Annette Ansong; Arash Sabati; Hoang H Nguyen; Tarique Hussain; Danyal Khan; David A Parra; Jennifer A Su; Jyoti K Patel; Christina Ronai; Monique Bohun; Bishara J Freij; Matthew J O'Connor; Joseph W Rosanno; Aamisha Gupta; Arash Salavitabar; Adam L Dorfman; Jesse Hansen; Olivia Frosch; Elizabeth L Profita; Shiraz Maskatia; Deepika Thacker; Shubhika Shrivastava; Tyler H Harris; Brian Feingold; Stuart Berger; Michael Campbell; Salim F Idriss; Srikant Das; Markus S Renno; Ken Knecht; S Yukiko Asaki; Sunil Patel; Ravi Ashwath; Renata Shih; John Phillips; Bibhuti Das; Preeti Ramachandran; Eyal Sagiv; Aarti H Bhat; Jonathan N Johnson; Nathaniel W Taggart; Jason Imundo; Natasha Nakra; Shashank Behere; Anjlee Patel; Avichal Aggarwal; Saif Aljemmali; Sean Lang; Sarosh P Batlivala; Daniel E Forsha; Gregory P Conners; Jana Shaw; Frank C Smith; Linda Pauliks; Joseph Vettukattil; Kenneth Shaffer; Stefanie Cheang; Sonia Voleti; Rajesh Shenoy; Rukmini Komarlu; Shea J Ryan; Christopher Snyder; Neha Bansal; Madhu Sharma; Jeffrey A Robinson; Sandra R Arnold; Christine M Salvatore; Madan Kumar; Michael A Fremed; Julie S Glickstein; Melissa Perrotta; William Orr; Tamika Rozema; Muthayipalayam Thirumoorthi; Charles J Mullett; Jocelyn Y Ang
Journal:  J Pediatr       Date:  2021-12-22       Impact factor: 4.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.